This is the information currently posted on the the clinical trails gov website regarding their diabetic foot ulcer study. Hopefully we'll get an update in the near future.
Study Type: Interventional (Clinical Trial) 1 EstimatedEnrollment: 138 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers. 7 ActualStudy Start Date: July 10, 2022 8 EstimatedPrimary Completion Date: December 1, 2023 9 EstimatedStudy Completion Date: March 1, 2024
This is the information currently posted on the the clinical...
-
- There are more pages in this discussion • 1,325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
-0.180(6.62%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.65 | $2.53 | $4.356M | 1.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 29641 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 22158 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |